The need for a new inhaler

Abstract

Inhalation therapy is and will remain the most important and most effective form of treatment for airway diseases such as asthma and COPD. Appropriate delivery of drugs to the airways has the potential of reaching high topical efficacy with limited or no systemic side effects. Novolizer® offers a number of technical features which can help to improve compliance, safety, efficacy and costs of asthma and COPD therapy. It will eventually be available with different medications thus fulfilling the recommendation of one inhaler for different drugs which will make the Novolizer® an ideal device in patients with asthma or COPD.